Incidence and mortality rates of breast and gynecologic cancers and human development index in the pan-American region.

Authors

null

Jeovany Martínez-Mesa

Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil

Jeovany Martínez-Mesa , Gustavo Werutsky , Stefan Michiels , Carlos Alberto Sampaio-Filho , Alfonso Duenas , Juan Jose Zarba , Max S. Mano , Cynthia Mayte Villarreal-Garza , Henry Leonidas Gomez , Carlos H. Barrios

Organizations

Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil, Service de Biostatistique et d’Epidémiologie, Gustave Roussy, Villejuif, France, Clinica AMO, Salvador, Brazil, Instituto Nacional de Cancerologia, Mexico City, Mexico, Centro Médico San Roque, San Miguel de Tucumán, Argentina, Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru, PUCRS School of Medicine, Porto Alegre, Brazil

Research Funding

No funding sources reported

Background: Breast and gynecologic cancers incidence and mortality rates differ between geographical regions. We aim to evaluate if disparities in incidence and mortality cancer rates among women in the Pan-American countries could be related to the country human development index (HDI). Methods: This ecological analysis includes 28 countries from the Pan-American region. Age-standardized incidence and mortality rates per 100.000, mortality/incidence ratios for breast , cervical cancer, ovarian cancer and corpus uteri cancer obtained from GLOBOCAN 2012. Data were log-transformed because of strong skewness. The information on HDI was gathered from the UNDP 2012 report. Pearson’s correlation test and simple linear regression were performed in Stata 12. Results: HDI was strongly and positively associated with breast and ovarian cancers incidence and mortality rates. HDI was negative associated with cervical cancer incidence and mortality rates and also with breast and cervical cancers ratio. HDI was not associated with corpus uteri cancer estimative. Linear regression coefficients (β) between HDI and each cancer log-rate are shown in the Table. Conclusions: HDI should be considered as an indicator explaining inequalities in incidence and mortality rates of breast, cervical and ovarian cancer in women between countries in the Pan-American region.

Cancer rates per 100,000 (log-transformed) Linear regression coefficient
β (95%CI) p-value*
Breast cancer incidence 4.03 (2.61;5.45) <0.001
Breast cancer mortality 1.76 (0.32;3.21) 0.019
Breast cancer mortality/incidence ratio -0.26 (-0.42;-0.10) 0.003
Cervical cancer incidence -3.28 (-4.78;-1.78) <0.001
Cervical cancer mortality -4.63 (-6.1;-3.17) <0.001
Cervical cancer mortality/incidence ratio -0.89 (-1.16;-0.62) <0.001
Corpus uteri cancer incidence 2.37 (-0.33;5.06) 0.083
Corpus uteri cancer mortality 0.07 (-2.68;2.82) 0.960
Corpus uteri mortality/incidence ratio -0.07 (-1.06;0.92) 0.885
Ovarian cancer incidence 3.26 (1.78;4.75) <0.001
Ovarian cancer mortality 1.82 (0.44;3.20) 0.012
Ovarian cancer mortality/incidence ratio -0.42 (-0.91;0.06) 0.086

*Wald test.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Cancer Prevention/Epidemiology

Track

Cancer Prevention/Epidemiology

Sub Track

Epidemiology

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 1596)

DOI

10.1200/jco.2014.32.15_suppl.1596

Abstract #

1596

Poster Bd #

378

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Annual Meeting

The effect of advances in management of uterine-serous-carcinoma on population mortality.

First Author: Aifen Wang

Abstract

2024 ASCO Annual Meeting

Cancer in Southeast Asia: A comparative analysis of 2022 incidence and mortality data.

First Author: Edward Christopher Christopher Dee

First Author: Sahana Somasegar

First Author: Justin Michael Barnes